PPARGC1A and amyotrophic lateral sclerosis: Moreover, it was also suggested that activation of SIRT3/PGC1-α/MnSOD pathways could also generate alleviating effect on Parkinson’s disease, Alzheimer’s disease, and amyotrophic lateral sclerosis [383,384,385].